Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Revue des Maladies Respiratoires is Scopus-indexed (Q4, CiteScore 1.1), WoS SCIE. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 0761-8425Verify ISSN ↗1776-2588Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$3,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 130 / 165 | 21st | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1984–present, best quartile Q4, CiteScore 1.1.
Revue des Maladies Respiratoires is Q4 in Pulmonary and Respiratory Medicine (rank 130 of 165), by CiteScore 2025.
Revue des Maladies Respiratoires is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.1, which places it in quartile Q4 at the 21st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.188, quartile Q4, with an H-index of 36.
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Revue des Maladies Respiratoires is published by Elsevier Masson s.r.l. Its print ISSN is 0761-8425 and its online ISSN is 1776-2588.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Revue des Maladies Respiratoires has an h-index of 40 and a 2-year mean of 0.24 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q4. On 2-year citations it ranks #138 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Revue des Maladies Respiratoires published 159 papers in 2025; its busiest recent year was 2018 with 1,420. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from France (86.6%), Belgium (4.1%) and Morocco (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.